{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:04:06Z","timestamp":1761581046037,"version":"3.40.4"},"reference-count":173,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ctrv.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:47:23Z","timestamp":1355273243000},"page":"328-339","source":"Crossref","is-referenced-by-count":37,"title":["Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations"],"prefix":"10.1016","volume":"39","author":[{"given":"Carmine","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Torri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ardizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Giacomo","family":"Betta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Alberto","family":"Bertazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni Angelo","family":"Casalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Fava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bice","family":"Fubini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Trodella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Zompatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2012.11.004_b0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/COC.0b013e3181d31f02","article-title":"Expert opinions of the first Italian consensus conference on the management of malignant pleural mesothelioma","volume":"34","author":"Pinto","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0010","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.ctrv.2012.11.004_b0015","unstructured":"Marinaccio A. Quarto Rapporto Registro Nazionale Mesoteliomi ReNaM 2012, ongoing."},{"key":"10.1016\/j.ctrv.2012.11.004_b0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0025","unstructured":"Howlader N, Noone A.M, Krapcho M, et al. SEER cancer statistics review, 1975\u20132008, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2008\/, based on November 2010 SEER data submission, posted to the SEER web site, 2011."},{"key":"10.1016\/j.ctrv.2012.11.004_b0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(05)70471-X","article-title":"Survival from rare cancer in adults: a population-based study","volume":"7","author":"Gatta","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1023\/A:1026300619747","volume":"14","author":"Montanaro","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ctrv.2012.11.004_b0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.20820","article-title":"Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models","volume":"115","author":"Marinaccio","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"119","key":"10.1016\/j.ctrv.2012.11.004_b0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global magnitude of reported and unreported mesothelioma","volume":"2011","author":"Park","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ctrv.2012.11.004_b0055","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.bjc.6601638","article-title":"The Mesothelioma epidemic in Western Europe: an update","volume":"90","author":"Pelucchi","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0060","unstructured":"NTP National Toxicology Program. Report on Carcinogens, U.S. Department of Health and Human Services, Public Health Service, Research Triangle Park; 2009."},{"volume":"100 C","year":"2012","series-title":"2011 a review of human carcinogens: metals, arsenic, dusts, and fibres","key":"10.1016\/j.ctrv.2012.11.004_b0065"},{"key":"10.1016\/j.ctrv.2012.11.004_b0070","unstructured":"Chrysotile Asbestos Expert Panel. Chrysotile Asbestos Consensus Statement and Summary, Montreal, Quebec, November 13\u201314, 2007."},{"key":"10.1016\/j.ctrv.2012.11.004_b0075","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1164\/rccm.200412-1731OC","article-title":"Residential proximity to naturally occurring asbestos and mesothelioma risk in California","volume":"172","author":"Pan","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0080","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1289\/ehp.10195","article-title":"Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy","volume":"115","author":"Ferrante","year":"2007","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ctrv.2012.11.004_b0085","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/oem.2009.047019","article-title":"Non-occupational exposure to asbestos and malignant mesothelioma in the Italian national registry of mesotheliomas","volume":"67","author":"Mirabelli","year":"2010","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0090","unstructured":"Marinaccio A. Terzo Rapporto Registro Nazionale Mesoteliomi ReNaM. Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro, Roma; 2010."},{"year":"2006","series-title":"IARC: monographs on the evaluation of the carcinogenic risk of chemicals to man","key":"10.1016\/j.ctrv.2012.11.004_b0095"},{"volume":"81","year":"2002","series-title":"IARC: man-made mineral fibres","key":"10.1016\/j.ctrv.2012.11.004_b0100"},{"key":"10.1016\/j.ctrv.2012.11.004_b0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/08958370903521224","article-title":"Refractory ceramic fiber (RCF) toxicity and epidemiology: a review","volume":"22","author":"Utell","year":"2010","journal-title":"Inhal Toxicol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0110","unstructured":"NTP \u2013 National Toxicology Program. Report on carcinogens. background document for glass wool fibres. US Dept. Health, Research Triangle Park; 2009."},{"key":"10.1016\/j.ctrv.2012.11.004_b0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0013-9351(81)90143-2","article-title":"Comparative pulmonary responses to inhaled inorganic fibers with asbestos and fiberglass","volume":"24","author":"Lee","year":"1981","journal-title":"Environ Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2486\/indhealth.39.168","article-title":"A trial on the quantitative risk assessment of man-made mineral fibers by the rat intraperitoneal administration assay using the JFM standard fibrous samples","volume":"39","author":"Adachi","year":"2001","journal-title":"Ind Health"},{"key":"10.1016\/j.ctrv.2012.11.004_b0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/oem.53.12.813","article-title":"Induction of mesothelioma after intrapleural inoculation of F344 rats with silicon carbide whiskers or continuous ceramic filaments","volume":"53","author":"Johnson","year":"1996","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nnano.2008.111","article-title":"Carbon nanotubes introduced into the abdominal cavity of mice show asbestos like pathogenicity in a pilot study","volume":"3","author":"Poland","year":"2008","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2131\/jts.33.105","article-title":"Induction of mesothelioma in p53 +\/\u2212 mouse by intraperitoneal application of multi-wall carbon nanotube","volume":"33","author":"Takagi","year":"2008","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.ctrv.2012.11.004_b0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2131\/jts.34.65","article-title":"Induction of mesotheliomaby a single intrascrotal administration of multi-wall carbon nanotube in intact male fischer 344 rats","volume":"34","author":"Sakamoto","year":"2009","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.ctrv.2012.11.004_b0145","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/toxsci\/kfp100","article-title":"Absence of carcinogenic response to multiwall carbon nanotubes in a 2-years bioassay in the peritoneal cavity of the rat","volume":"110","author":"Muller","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ctrv.2012.11.004_b0150","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10552-009-9357-4","article-title":"Ionizing radiation: a risk factor for mesothelioma","volume":"20","author":"Goodman","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ctrv.2012.11.004_b0155","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/ijc.22592","article-title":"Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples","volume":"120","author":"Kjaerheim","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0160","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bjc.6605848","article-title":"SV40 associated miRNAs are not detectable in mesotheliomas","volume":"103","author":"Gee","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mrrev.2007.08.001","article-title":"Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor","volume":"658","author":"Ugolini","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajim.20451","article-title":"Mesothelioma in blood related subjects: report of 11 clusters among 1954 italy cases and review of the literature","volume":"50","author":"Ascoli","year":"2007","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mrrev.2008.02.002","article-title":"Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases","volume":"659","author":"Neri","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mrfmmm.2011.01.001","article-title":"XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study","volume":"708","author":"Betti","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0185","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2012.11.004_b0190","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2012.11.004_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2113\/GSELEMENTS.3.6.407","article-title":"Toxic potential of mineral dusts","volume":"3","author":"Fubini","year":"2007","journal-title":"Elements"},{"key":"10.1016\/j.ctrv.2012.11.004_b0200","unstructured":"NIOSH Current intelligence bulletin: asbestos fibers and other elongate mineral particles: state of the science and roadmap for research, version 4 \u2013 April 2011. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health."},{"key":"10.1016\/j.ctrv.2012.11.004_b0205","series-title":"Mechanisms of mineral fibre carcinogenesis","volume":"vol. 140","author":"Kane","year":"1996"},{"key":"10.1016\/j.ctrv.2012.11.004_b0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10937404.2011.556051","article-title":"Role of mutagenicity in mineral fiber-induced carcinogenicity and other diseases","volume":"14","author":"Huang","year":"2011","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.ctrv.2012.11.004_b0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-069X-7-4","article-title":"Translocation pathways for inhaled asbestos fibers","volume":"7","author":"Miserocchi","year":"2008","journal-title":"Environ Health"},{"key":"10.1016\/j.ctrv.2012.11.004_b0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0019-5278.43261","article-title":"Susceptibility and resistance in the genesis of asbestos-related mesothelioma","volume":"12","author":"Bianchi","year":"2008","journal-title":"Ind J Occup Environ Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts myths and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J Cell Physiol"},{"year":"1991","series-title":"Asbestos in public and commercial buildings","author":"HEI health effects institute: asbestos research","key":"10.1016\/j.ctrv.2012.11.004_b0230"},{"key":"10.1016\/j.ctrv.2012.11.004_b0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/annhyg\/44.8.565","article-title":"The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure","volume":"44","author":"Hodgson","year":"2000","journal-title":"Ann Occup Hyg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0240","series-title":"Cancer epidemiology and prevention","first-page":"659","article-title":"Pleural and peritoneal neoplasms","author":"Boffetta","year":"2006"},{"key":"10.1016\/j.ctrv.2012.11.004_b0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10408440802273156","article-title":"A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type","volume":"38","author":"Berman","year":"2008","journal-title":"Crit Rev Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.ctrv.2012.11.004_b0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/annhyg\/46.suppl_1.90","article-title":"Mortality in miners and millers of crocidolite in western australia: follow-up to 1999","volume":"46","author":"Musk","year":"2002","journal-title":"Ann Occup Hyg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/bjc.1982.15","article-title":"Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment","volume":"45","author":"Peto","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0260","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/oem.2003.008128","article-title":"Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom Western Australia","volume":"61","author":"Berry","year":"2004","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0265","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/ijc.23609","article-title":"Long-term mortality from pleural and peritoneal cancer after exposure to asbestos. Possible role of asbestos clearance","volume":"123","author":"Barone Adesi","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0270","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ctrv.2012.11.004_b0275","doi-asserted-by":"crossref","unstructured":"Tan E, Warren N. Mesothelioma mortality in Great Britain. The revised risk and two-stage clonal expansion models. Health and Safety Excutive (HSE); 2011. Research Report 876.","DOI":"10.1136\/oemed-2011-100382.194"},{"key":"10.1016\/j.ctrv.2012.11.004_b0280","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/ajim.20844","article-title":"Asbestosis and mesothelioma among British asbestos workers (1971\u20132005)","volume":"53","author":"Harding","year":"2010","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10937404.2011.556049","article-title":"Non-neoplastic and neoplastic pleural endpoints following fiber exposure","volume":"14","author":"Broaddus","year":"2011","journal-title":"J Toxicol Environ Hlt B"},{"key":"10.1016\/j.ctrv.2012.11.004_b0290","series-title":"Rapporto sui tumori a Milano","volume":"XXXIII-IV","author":"Russo","year":"2007"},{"key":"10.1016\/j.ctrv.2012.11.004_b0295","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1196\/annals.1371.042","article-title":"The economic costs of health service treatments for asbestos-related mesothelioma deaths","volume":"1076","author":"Watterson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctrv.2012.11.004_b0300","first-page":"331","article-title":"Gruppo regionale veneto sui mesoteliomi maligni. I fattori che influenzano in Italia la domanda e il riconoscimento dei mesoteliomi di origine professionale","volume":"35","author":"Merler","year":"2011","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.ctrv.2012.11.004_b0305","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5858\/arpa.2010-0604-RA","article-title":"Immunohistochemistry and molecular diagnostic of pleural malignant mesothelioma","volume":"136","author":"Betta","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0310","unstructured":"Butnor KJ, Beasley MB. Cagle PT, et al. Protocol for the examination of specimens from patients with malignant pleural mesothelioma. College of American Pathologists\u2019 Recommendations; 2011: 1\u201312."},{"key":"10.1016\/j.ctrv.2012.11.004_b0315","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/dc.21398","article-title":"Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations","volume":"39","author":"Ikeda","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0320","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0325","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","article-title":"Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma","volume":"6","author":"Hollevoet","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0330","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","article-title":"Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma","volume":"181","author":"Hollevoet","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0335","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.rmed.2009.05.017","article-title":"Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis","volume":"104","author":"Luo","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0340","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.2009.26.9944","article-title":"Soluble mesothelin-related peptide and osteopontin as markers of response in malignant mesothelioma","volume":"28","author":"Wheatley-Price","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0345","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0350","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cellsig.2010.10.003","article-title":"A bone morphogenetic proteins: a critical review","volume":"23","author":"Bragdon","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.ctrv.2012.11.004_b0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3816\/CLC.2010.n.048","article-title":"Individualizing mesothelioma treatment: small steps into a brighter future","volume":"11","author":"Garland","year":"2010","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0360","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma. A consensus statement from the international mesothelioma interest group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0365","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cellsig.2009.12.007","article-title":"Controlling of bone morphogenetic protein signalling","volume":"22","author":"Zeng","year":"2010","journal-title":"Cellular Signal"},{"key":"10.1016\/j.ctrv.2012.11.004_b0370","first-page":"1","article-title":"BTS statement on malignant mesothelioma in the UK","volume":"62","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.ctrv.2012.11.004_b0375","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.semtcvs.2009.06.011","article-title":"Current trends in radiologic management of malignant pleural mesothelioma","volume":"21","author":"Gill","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0380","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1259\/bjr\/55980445","article-title":"Multidetector CT imaging of pleura: comparison of two contrast infusion protocols","volume":"84","author":"Raj","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0720-048X(01)00426-0","article-title":"Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases","volume":"41","author":"Metintas","year":"2002","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0390","first-page":"487","article-title":"CT in differential diagnosis of diffuse pleural disease","volume":"154","author":"Leung","year":"1990","journal-title":"Am J Rad"},{"key":"10.1016\/j.ctrv.2012.11.004_b0395","first-page":"502","article-title":"Evaluation of pleural disease using MR and CT with special reference to malignant pleural mesothelioma","volume":"42","author":"Knuuttila","year":"2001","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0400","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.118.3.604","article-title":"MRI and CT in the differential diagnosis of pleural disease","volume":"118","author":"Hierholzer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ctrv.2012.11.004_b0405","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1052-3359(25)00650-7","article-title":"CT and MR imaging in the evaluation of pleural masses","volume":"3","author":"Heelan","year":"1994","journal-title":"Chest Surg Clin North Am"},{"key":"10.1016\/j.ctrv.2012.11.004_b0410","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.125.2.489","article-title":"Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging","volume":"125","author":"Duysinx","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ctrv.2012.11.004_b0415","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/JTO.0b013e3181c0a7ff","article-title":"Clinical value of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study","volume":"4","author":"Yildirim","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0420","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2214\/ajr.172.4.10587144","article-title":"Staging of malignant pleural mesothelioma: comparison of CT and MR imaging","volume":"172","author":"Heelan","year":"1999","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0425","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/RLI.0b013e3181817b3d","article-title":"Computed tomography, positron emission tomography, positron emission tomography\/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma-initial results","volume":"43","author":"Plathow","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0430","first-page":"111","article-title":"Additional value of hybrid PET\/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma","volume":"8","author":"Ambrosini","year":"2005","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.ctrv.2012.11.004_b0435","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00330-008-0918-9","article-title":"Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT","volume":"18","author":"Plathow","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0440","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1378\/chest.129.6.1570","article-title":"Dynamic contrast enhanced MRI of malignant pleural mesothelioma\u2013\u2013a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome","volume":"129","author":"Giesel","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ctrv.2012.11.004_b0445","first-page":"41","article-title":"Modeling of mesothelioma growth demonstrates weaknesses of current response criteria","volume":"52","author":"Oxnard","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0450","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11307-010-0426-6","article-title":"Current evidence base of FDG-PET\/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment","volume":"13","author":"Basu","year":"2011","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0455","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","article-title":"Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans","volume":"48","author":"Francis","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0460","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European respiratory society and the European society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"issue":"Suppl 5","key":"10.1016\/j.ctrv.2012.11.004_b0465","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/annonc\/mdq173","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Stahel","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0470","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesotelioma. A consensus statement from the international mesothelioma interest group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0475","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MCP.0b013e3282fe9a04","article-title":"Image-guided pleural biopsy","volume":"14","author":"Rahman","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0480","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(03)13079-6","article-title":"Standard pleural biopsy versus CT guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial","volume":"361","author":"Maskell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2012.11.004_b0485","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccm.2006.02.001","article-title":"Imaging of pleural disease","volume":"27","author":"Qureshi","year":"2006","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0490","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1378\/chest.120.6.1798","article-title":"Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma","volume":"120","author":"Adams","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ctrv.2012.11.004_b0495","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1378\/chest.09-0884","article-title":"Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial","volume":"137","author":"Metintas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ctrv.2012.11.004_b0500","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: diagnosis","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0505","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0954-6111(98)90100-7","article-title":"Medical thoracoscopy, results and complications in 146 patients: a retrospective study","volume":"92","author":"Hansen","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.ctrv.2012.11.004_b0510","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12094-011-0617-x","article-title":"Clinical-therapeutic management of thoracoscopy in pleural effusion: a groundbreaking technique in the twenty-first century","volume":"13","author":"Galbis","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0515","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1752-699X.2011.00254.x","article-title":"Outcomes and complications following medical thoracoscopy","volume":"6","author":"Brims","year":"2012","journal-title":"Clin Respir J"},{"year":"2010","author":"American joint committee on cancer: pleural mesothelioma","key":"10.1016\/j.ctrv.2012.11.004_b0520"},{"key":"10.1016\/j.ctrv.2012.11.004_b0525","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/JTO.0b013e31820ce2c7","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0530","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.athoracsur.2009.05.022","article-title":"Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma","volume":"88","author":"Rice","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0535","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1158\/1078-0432.CCR-07-5283","article-title":"Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma","volume":"14","author":"Tournoy","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0540","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1510\/icvts.2009.213611","article-title":"Staging algorithm for diffuse malignant pleural mesotelioma","volume":"10","author":"Zielinski","year":"2010","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0545","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/cncr.24886","article-title":"Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases","volume":"116","author":"Richards","year":"2010","journal-title":"Cancer"},{"issue":"371","key":"10.1016\/j.ctrv.2012.11.004_b0550","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","article-title":"Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial","volume":"17","author":"Muers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2012.11.004_b0555","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"Van Meerbeeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0560","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0565","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemona\u0131ve patients with malignant pleural mesothelioma: results of the international expanded access program","volume":"3","author":"Santoro","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0570","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials","volume":"99","author":"Ceresoli","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0575","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2011.41.5869","article-title":"Multi-center, double-blind, placebo-controlled, randomized phase II trial of gemcitabine\/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma","volume":"30","author":"Kindler","year":"2012","journal-title":"J Clin Oncol"},{"issue":"Suppl. 15","key":"10.1016\/j.ctrv.2012.11.004_b0580","article-title":"IFCT-GFPC-0701 MAPS trial, a multicenter randomized phase II\/III trial of pemetrexed-cisplatin with or without bevacizumab in patients with malignant pleural mesothelioma","volume":"28","author":"Zalcman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0585","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.09.9887","article-title":"Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma","volume":"26","author":"Jassem","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0590","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.lungcan.2007.08.031","article-title":"Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option","volume":"60","author":"Razak","year":"2008","journal-title":"Lung Cancer"},{"issue":"Suppl. 18","key":"10.1016\/j.ctrv.2012.11.004_b0595","article-title":"Pemetrexed in second-line therapy in patients with malignant pleural mesotelioma","volume":"25","author":"Serke","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0600","unstructured":"De Vincenzo F, Zucali PA, Ceresoli GL, et al. Re-treatment with pemetrexed based chemotherapy in patients with malignant pleural mesothelioma (MPM): an observational study. In: Proceedings of the IX International Conference of the IMIG (International Mesothelioma Interest Group), Amsterdam (The Netherlands); 2008. Abstract 163."},{"key":"10.1016\/j.ctrv.2012.11.004_b0605","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1378\/chest.128.3.1431","article-title":"Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions","volume":"128","author":"Kolschmann","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ctrv.2012.11.004_b0610","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5223(96)70342-2","article-title":"The importance of surgical staging in the treatment of malignant pleural mesothelioma","volume":"111","author":"Rusch","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0615","first-page":"367","article-title":"Pleurectomy\/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma","volume":"9","author":"Rusch","year":"1997","journal-title":"Sem Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)36577-8","article-title":"The role of extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"102","author":"Rusch","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0625","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.1993.11.6.1172","article-title":"Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma","volume":"11","author":"Sugarbaker","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0630","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01243894-200602000-00014","article-title":"Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma","volume":"1","author":"Sugarbaker","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0635","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1010-7940(02)00273-7","article-title":"The management of malignant pleural mesothelioma; single centre experience in 10 years","volume":"22","author":"Aziz","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0640","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejcts.2003.12.001","article-title":"The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma","volume":"25","author":"Pilling","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0645","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.athoracsur.2005.06.014","article-title":"Extended surgical staging for potentially resectable malignant pleural mesothelioma","volume":"80","author":"Rice","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0650","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.athoracsur.2004.01.034","article-title":"The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma","volume":"78","author":"Stewart","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0655","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jtcvs.2005.11.044","article-title":"The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma","volume":"131","author":"Edwards","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0660","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.thorsurg.2004.06.006","article-title":"Patterns of failure following surgical resection for malignant pleural mesothelioma","volume":"14","author":"Janne","year":"2004","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.ctrv.2012.11.004_b0665","first-page":"362","article-title":"Recent progress in treatment of malignant pleural mesothelioma","volume":"9","author":"Mahe","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ctrv.2012.11.004_b0670","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejcts.2007.01.064","article-title":"Case-control study between extrapleural pneumonectomy and radical pleurectomy\/decortication for pathological N2 malignant pleural mesothelioma","volume":"31","author":"Martin-Ucar","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0675","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejcts.2005.10.008","article-title":"Multimodality approach in management of malignant pleural mesothelioma","volume":"29","author":"Neragi-Miandoab","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0680","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0761-8417(05)84833-3","article-title":"Malignant pleural mesothelioma. Role of surgery","volume":"61","author":"Grunenwald","year":"2005","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.ctrv.2012.11.004_b0685","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2005.03.041","article-title":"Hemithoracic radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma","volume":"63","author":"Gupta","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2012.11.004_b0690","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5223(03)00207-1","article-title":"Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma","volume":"126","author":"Flores","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0695","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial","volume":"1","author":"Flores","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0700","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0705","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy cersus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0710","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.anndiagpath.2008.11.001","article-title":"Surgery for malignant pleural mesothelioma","volume":"13","author":"Rice","year":"2009","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0715","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","article-title":"Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"22","author":"Weder","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0720","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0725","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0730","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11864-011-0154-4","article-title":"Surgical treatment of malignant pleural mesothelioma","volume":"12","author":"Kaufman","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0735","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0740","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-10862-4_7","article-title":"Surgical therapy of mesothelioma","volume":"189","author":"Rice","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.ctrv.2012.11.004_b0745","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0750","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1634\/theoncologist.2010-0185","article-title":"What is the role of radiotherapy in malignant pleural mesothelioma?","volume":"16","author":"Price","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2012.11.004_b0755","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2006.06.002","article-title":"The role of radiation therapy in malignant pleural mesothelioma: a systematic review","volume":"80","author":"Ung","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0760","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ctrv.2012.11.004_b0765","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6601957","article-title":"A randomised trial of single dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma","volume":"91","author":"Bydder","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2012.11.004_b0770","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2007.05.022","article-title":"A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma","volume":"84","author":"O\u2019Rourke","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0775","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0360-3016(98)00409-X","article-title":"Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura: a single institution experience with 189 patients","volume":"43","author":"De Graaf-Strukowska","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2012.11.004_b0780","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-8140(03)00229-9","article-title":"Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch\u2013Belgian survey","volume":"68","author":"De Ruysscher","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0785","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1440-1673.1994.tb00177.x","article-title":"Radiotherapy in the treatment of malignant mesothelioma with special reference to its use in palliation","volume":"38","author":"Davis","year":"1994","journal-title":"Aust Radiol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0790","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0936-6555(05)80582-5","article-title":"The role of palliative radiotherapy in malignant mesothelioma","volume":"3","author":"Bissett","year":"1991","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0795","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1183\/09031936.96.09122565","article-title":"Effect of hemithorax irradiation alone or combined with doxorubicin and cyclofosfamide in 47 pleural mesotheliomas: a nonrandomized phase II study","volume":"9","author":"Linden","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ctrv.2012.11.004_b0800","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0003-4975(96)01228-3","article-title":"Patterns of failure after trimodality therapy for malignant mesothelioma","volume":"63","author":"Baldini","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0805","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s002680020021","article-title":"Treatment of malignant mesothelioma","volume":"25","author":"Jaklitsch","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0810","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A phase II trial of surgical resection and adjuvant high-dose hemothoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0815","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy for malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0820","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"Van Meerbeeck","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0825","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0360-3016(02)04151-2","article-title":"Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma","volume":"55","author":"Ahamed","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2012.11.004_b0830","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00130404-200311000-00008","article-title":"Promising early local control of malignant pleural mesothelioma following postoperative Intensity Modulated Radiotherapy (IMRT) to the chest","volume":"9","author":"Ahamed","year":"2003","journal-title":"Cancer J"},{"key":"10.1016\/j.ctrv.2012.11.004_b0835","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ijrobp.2007.02.047","article-title":"Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy","volume":"68","author":"Allen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2012.11.004_b0840","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jtcvs.2008.12.045","article-title":"Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors","volume":"138","author":"Yan","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctrv.2012.11.004_b0845","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2012.11.004_b0850","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","article-title":"Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2012.11.004_b0855","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/JTO.0b013e3181b9eb85","article-title":"Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques","volume":"4","author":"Hill-Kayser","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0860","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2011.09.025","article-title":"Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series","volume":"101","author":"Tonoli","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2012.11.004_b0865","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1378\/chest.103.4_Supplement.382S","article-title":"Pleurectomy\/decortication and adjuvant therapy for malignant mesothelioma","volume":"103","author":"Rusch","year":"1993","journal-title":"Chest"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737212002368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737212002368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:47:04Z","timestamp":1745419624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737212002368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":173,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0305737212002368"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2012.11.004","relation":{},"ISSN":["0305-7372"],"issn-type":[{"type":"print","value":"0305-7372"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}